TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$0.75
+0.02 (+2.66%)
As of Jun 30, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
78.11M
Net Income
-37,781,713
Gross Margin
67.7%
Profit Margin
-48.4%
Rev Growth
+24.7%
D/E Ratio
8.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 78.11M 62.65M 7.47M 7.60M
Gross Profit 52.87M 42.41M 2.11M 2.15M
Operating Income -33,711,321 -24,334,447 1.36M 1.26M
Net Income -37,781,713 -27,272,651 1.27M 1.28M
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Rev Growth +24.7% +24.7% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 14.47M 14.47M 9.64M 8.55M
Total Equity 1.64M 1.64M 26.51M 24.38M
D/E Ratio 8.82 8.82 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -33,094,972 -25,216,733 2.01M 2.00M
Free Cash Flow 1.14M 1.46M